Skip to main content
SpringerLink
Log in

Phase I–II study of intratumor immunotherapy with BCG cell wall skeleton plus P3

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

A vaccine composed of BCG cell wall skeleton (CWS) and a trehalose dimycolate called P3, attached to microdroplets of mineral oil, was evaluated for activity and toxicity when injected into tumor nodules. A total of 99 nodules in 23 patients with metastatic melanoma and carcinoma of the breast were treated overa dose range of 150 μg, 300 μg, and 600 μg cell wall skeleton plus P3 per cm of nodule diameter. At least one injected nodule resolved in 11 of the 23 patients (48%), and 34% of all injected nodules resolved. Response correlated with nodule size of 1 cm or less, cutaneous location, and immunocompetence measured by PPD and recall skin testing. Toxicity became manifest in ulceration (61% of patients), fever (52%), and pain (26%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams, A., Ciorbaru, R., Petit, J., Lederer, E.: Isolation and properties of a macromolecular, water-soluble immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 69, 851–854 (1972)

    Google Scholar 

  2. Azuma, I., Ribi, E. E., Meyer, T. J., Zbar, B.: Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J. Natl. Cancer Inst. 52, 95–101 (1974)

    Google Scholar 

  3. Bornstein, R. S., Mastrangelo, M. J., Sulit, H., Darwin, C., Yarbro, J. W., Prehn, L., Prehn, R. T.: Immunotherapy of melanoma with intralesional BCG. Natl. Cancer Inst. Monogr. 39, 213–220 (1973)

    Google Scholar 

  4. Chedid, L., Parant, M., Parant, F., Gustafson, R. H., Berger, F. M.: Biological study of a nontoxic, water-soluble, immunoadjuvant from mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 69, 855–858 (1972)

    Google Scholar 

  5. Cuttner, J., Bekesi, J. G., Holland, J. F.: Chemoimmunotherapy of acute leukemia using MER. Proc. Am. Assoc. Cancer Res. 17, 196 (1976)

    Google Scholar 

  6. Eilber, F. R., Morton, D. L., Holmes, E. C., Sparks, F. C., Ramming, K. P.: Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N. Engl. J. Med. 294, 237–240 (1976)

    Google Scholar 

  7. Gutterman, J. U., Mavligit, G., McBride, C., Frei, E. III, Freireich, E. J., Hersh, E. M.: Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1973 1, 1208–1212

    Google Scholar 

  8. Klein, E., Holtermann, O. A., Papermaster, B., Milgrom, H., Rosner, D., Kelin, L., Walker, K. J., Zbar, B.: Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives. Natl. Cancer Inst. Monogr. 39, 229–239 (1973)

    CAS  Google Scholar 

  9. Lieberman, R., Wybran, J., Epstein, W.: The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma. Cancer 35, 756–777 (1975)

    Google Scholar 

  10. McKneally, M. F., Maver, C., Kausel, H. W., Alley, R. D.: Regional immunotherapy with intrapleural BCG for lung cancer. J. Thorac. Cardiovasc. Surg. 72, 333–338 (1976)

    Google Scholar 

  11. Meyer, T. J., Ribi, E. E., Azuma, I., Zbar, B.: Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J. Natl. Cancer Inst. 52, 103–111 (1974)

    Google Scholar 

  12. Morton, D. L., Eilber, F. R., Malmgren, R. A., Wood, W. C.: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158–164 (1970)

    CAS  PubMed  Google Scholar 

  13. Nathanson, L.: Regression of intradermal malignant melanoma after intralesional injection of mycobacterium bovis strain BCG. Cancer Chemother. Rep. 56, 659–665 (1972)

    Google Scholar 

  14. Pinsky, C. M., Hirshaut, Y., Oettgen, H. F.: Treatment of malignant melanoma by intratumoral injection of BCG. Natl. Cancer Inst. Monogr. 39, 225–228 (1973)

    Google Scholar 

  15. Ribi, E. E., Granger, D. L., Milner, K. C., et al.: Tumor regression caused by endotoxins and mycobacterial fractions. (Brief communication.) J. Natl. Cancer Inst. 55, 1253–1257 (1975)

    Google Scholar 

  16. Weiss, D. W., Stupp, Y., Many, N., Izak, G.: Treatment of acute myelocytic leukemia (AML) patients with MER tubercle bacillus fraction: A preliminary report. Transplant. Proc. 7 (Suppl.) 545–552 (1975)

    Google Scholar 

  17. Yamamura, Y., Yoshizake, K., Azuma, I., Yagura, T. S., Wanatabe, T.: Immunotherapy of human melanoma with cil-attached BCG cell wall skeleton. Gann 66, 355–363 (1975)

    Google Scholar 

  18. Yasumoto, K., Manabe, H., Ueno, M., Ohta, M., Ueda, H., Iida, A., Nomoto, K., Azuma, I., Yamamura, Y.: Immunotherapy of human lung cancer with BCG cell-wall skeleton. Gann 67, 787–795 (1976)

    Google Scholar 

Download references

Author information

Author notes

  1. S. P. Richman

    Present address: Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases, 59840, Hamilton, Montana, USA

Authors and Affiliations

  1. Section of Immunology, Department of Developmental Therapeutics, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Street, 77030, Houston, Texas, USA

    S. P. Richman, J. U. Gutterman, E. M. Hersh & E. E. Ribi

  2. Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases, 59840, Hamilton, Montana, USA

    J. U. Gutterman, E. M. Hersh & E. E. Ribi

Authors
  1. S. P. Richman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. U. Gutterman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. M. Hersh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. E. Ribi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richman, S.P., Gutterman, J.U., Hersh, E.M. et al. Phase I–II study of intratumor immunotherapy with BCG cell wall skeleton plus P3 . Cancer Immunol Immunother 5, 41–44 (1978). https://doi.org/10.1007/BF00199206

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199206

Keywords

Search

Navigation